Home > Insider Trading > Filing (0001104659-18-047445)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1737953	Replimune Group Inc.	REPL	Biological Products, (No Disgnostic Substances) (2836)	822082553

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1747586	U.a. Cooperatief Iii Fund Capital Forbion	C/O Forbion Capital Partners, Gooimeer 2-35 Naarden P7 1411 DC		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-07-24	994,688	$0.00	994,688	No	4	C	Indirect	See footnote
Common Stock	Acquisiton	2018-07-24	2,579,881	$0.00	3,574,569	No	4	C	Indirect	See footnote
Common Stock	Acquisiton	2018-07-24	1,013,547	$0.00	4,588,116	No	4	C	Indirect	See footnote
Common Stock	Acquisiton	2018-07-24	133,333	$15.00	4,721,449	No	4	P	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	See footnote
No	4	C	Indirect	See footnote
No	4	C	Indirect	See footnote
No	4	P	Indirect	See footnote

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrant (right to buy)	Acquisiton	2018-07-24	248,672	$0.00	248,672	$0.00
Series Seed Convertible Preferred Stock	Warrant (right to buy)	Disposition	2018-07-24	248,672	$0.00	248,672	$0.00
Common Stock	Series Seed Convertible Preferred Stock	Disposition	2018-07-24	994,688	$0.00	994,688	$0.00
Common Stock	Series A Convertible Preferred Stock	Disposition	2018-07-24	2,579,881	$0.00	2,579,881	$0.00
Common Stock	Series B Convertible Preferred Stock	Disposition	2018-07-24	1,013,547	$0.00	1,013,547	$0.00

Remaning Holdings	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
248,672	No	4	C	Indirect
0	No	4	C	Indirect
0	No	4	C	Indirect
0	No	4	C	Indirect
0	No	4	C	Indirect

Footnotes

In connection with the completion of the Issuer's initial public offering, each share of the Issuer's series seed convertible preferred stock, series A convertible preferred stock and series B convertible preferred stock (collectively, the "Preferred Stock") converted into shares of the Issuer's common stock on a 1-for-9.94688 basis without payment or consideration. The Preferred Stock had no expiration date.
The securities are held directly by Forbion Capital Fund III Cooperatief U.A. ("Forbion Coop"). Forbion III Management B.V. ("Forbion Management") is the director of Forbion Coop and may be deemed to have voting, investment and dispositive power with respect to the shares held by Forbion Coop. Forbion Management disclaims Section 16 beneficial ownership of the shares held by Forbion Coop, except to the extent, if any, of its pecuniary interest therein.
Reflects warrants to acquire shares of the Issuer's Series Seed Convertible Preferred Stock which automatically converted into warrants to acquire shares of the Issuer's common stock immediately prior to the completion of the Issuer's initial public offering on a 1-for-9.94688 basis without payment or consideration. The warrants have no expiration date. The exercise price is $1.01 per share of the Issuer's common stock.
Reflects the number of shares of applicable series of preferred stock held by the Reporting Person on an as-converted to common stock basis.